Manuela Pardeo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Interplay of Autoinflammation and Congenital Neutropenia: A Case of Chronic Nonbacterial Osteomyelitis in ELANE Cyclic Neutropenia, Successfully Treated With Anti-TNFα.

Interplay of Autoinflammation and Congenital Neutropenia: A Case of Chronic Nonbacterial Osteomyelitis in ELANE Cyclic Neutropenia, Successfully Treated With Anti-TNFα.

Journal: Pediatric blood & cancer

Published: April 24, 2026

Validation of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis.

Validation of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis.

Journal: Arthritis care & research

Published: November 20, 2025

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter study.

Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter study.

Journal: Pediatric rheumatology online journal

Published: May 23, 2025

Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS.

Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS.

Journal: Seminars in arthritis and rheumatism

Published: April 09, 2025

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis.

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 05, 2024

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).

Journal: Annals of the rheumatic diseases

Published: September 11, 2024

EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis.

EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 11, 2024

Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score.

Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 05, 2023

Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis.

Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis.

Journal: The Journal of rheumatology

Published: June 02, 2023

Efficacy and safety of emapalumab in macrophage activation syndrome.

Efficacy and safety of emapalumab in macrophage activation syndrome.

Journal: Annals of the rheumatic diseases

Published: December 18, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026